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Abstract We present the first and unique case of a
rapid-growing skull hemangioma in a patient with
Klippel–Trénaunay–Weber syndrome. This case report
provides evidence that not all rapid-growing, osteolytic
skull lesions need to have a malignant character but
certainly need a histopathological verification. This ma-
terial offers insight into the list of rare pathological
diagnoses in an infrequent syndrome.
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Introduction
Klippel–Trénaunay–Weber syndrome is a rare, congeni-
tal syndrome of unknown etiology, first described in
1900 by the French physicians Maurice Klippel and
Paul Trénaunay and in 1907 by the English physician
Frederic Parkes Weber. The syndrome is characterized
by a triad of port-wine stain, varicose veins, and soft
tissue and bony hypertrophy, potentially leading to var-
ious types of tumors, including bone and soft tissue
tumors [1]. The diagnosis of a skull hemangioma in a
patient with Klippel–Trénaunay–Weber (KTW) syn-
drome has not been described previously. Here, we de-
scribe the unique case of a patient with drug-resistant
epilepsy, Klippel–Trénaunay–Weber syndrome, and the
occurrence of a rapid-growing skull lesion.
Case report
A 45-year-old Caucasian woman presented in the out-
patient clinic with a rapidly growing subcutaneous le-
sion on the left parietal side of the skull. Since 6 months
before presentation, she had noticed an increase of the
growth rate of this lesion, which was slightly painful
when she would lie on it. Previously, a general surgeon
at another hospital took a biopsy of this lesion, but had
to stop the procedure soon after incision because of
substantial blood loss. The diagnosis could not be con-
firmed at that time. The patient had been known to
have Klippel–Trénaunay–Weber syndrome (KTW) since
adolescence, presenting with a nevus flammeus on the
right side of the face and varicose veins. In the past,
she had deep venous thrombosis, pulmonary embolism,
and cellulitis, all consistent with KTW syndrome.
A tiny lesion was already noticed 2 years earlier when
she underwent a right-sided anterior temporal lobectomy
plus amygdalohippocampectomy for drug-resistant
temporal lobe epilepsy. After this operation, she
remained seizure-free.
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Clinical examination revealed a left parietal painless
subcutaneous tumor of hard consistency, fixated to the
skull but not to the skin, approximately 5 cm in diam-
eter and protruding out about 3 cm from the skull sur-
face (Fig. 1). There were no skin defects. Additionally,
a smaller but highly similar lesion (diameter 2.2 cm,
protruding 0.8 cm) was palpated more inferior, close
to the lambdoid suture near the midline.
Computed tomography (CT) of the skull showed an
osteolytic lesion with a diameter of 4.5 cm in the left
parietal bone with destruction of both the external and
internal tabula of the skull. The extracranial portion of
the swelling consisted of a radial striped lesion without
skin defect (Fig. 2a–b). The second osteolytic lesion had
a diameter of 1.4 cm without an extracranial swelling
and destruction of only the external tabula of the skull.
Contrast-enhanced magnetic resonance imaging (MRI)
demonstrated invasion of the tumor to the level of the
dura mater, without dural enhancement or parenchymal
involvement (Fig. 2c–d). The first radiological differen-
tial diagnosis was a metastatic skull lesion from an un-
known primary tumor.
Because of evident growth and a probable malignant
tumor, it was decided to perform a left-sided parietal
craniectomy with resection of both lesions. The skin
and subcutaneous tissue could be easily separated from
the lesion (Fig. 3a). After craniectomy, both hard, skull-
fixed lesions could be resected. As suspected, there was
no dural involvement (Fig. 3b). After craniectomy and
Fig. 2 a Transverse and b
coronal CT, windowed to bone
setting, demonstrating destruction
of both the external and internal
tabula of the skull. Extracranial
radial striped calcified fragments
are present. c Sagittal T2-
weighted and d coronal FLAIR
MRI, demonstrating growth to the
level of the dura mater, without
parenchymal involvement
Fig. 1 Left parietal subcutaneous tumor, evidently protruding from the
skull surface. A second but smaller lesion (arrow) is present more
posterior and inferior to the large lesion
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meticulous hemostasis, a methyl methacrylate (Palacos®,
Zimmer Biomet, Warsaw, IN, USA) plasty was inserted and
fixated by mini-plates. The patient had a quick recovery and
left the hospital 4 days after operation.
Histopathology
The resected bone flap showed a hard, bone-like,
mushroom-shaped tumor (Fig. 4a). Underneath the large
tumor, significant bone erosion was present with de-
struction of both the tabula interna and externa
(Fig. 4b). The second, smaller tumor was similar in
appearance with destruction of only the external tabula.
Tissue was decalc if ied in two manners , using
Kristensen’s methodology and RDO Rapid Decalcifier.
Microscopically, collagenous proliferation with an evi-
dent increase in small capillaries was seen (Fig. 4c
and d). These vascular structures were lined with nor-
mally differentiated endothelium without atypical prolif-
eration. No mitotic spindles were identified. There was
no evidence for malignant transformation. There was
immunoreaction for anti-smooth muscle antibody
(ASMA). Blood vessels showed positive endothelial
markers CD31 and CD34 (Fig. 4e). There was no im-
munoreaction for tumor proliferation marker MIB-1
(Fig. 4f). The histopathological diagnosis of a benign
vascular lesion, consistent with hemangioma, was made.
Discussion
We present, to the best of our knowledge, the first and unique
case description of a skull hemangioma in a patient with KTW
syndrome.
KTW syndrome is a rare congenital malformation
syndrome of unknown etiology. Although the clinical
presentation can be extremely variable, the characteris-
tic triad is an association of (cutaneous) capillary
malformations, bone, and soft tissue hypertrophy and
varicosity [1]. In our case, the patient also had drug-
resistant epilepsy, however no association between the
KTW syndrome and epilepsy could be identified in the
literature.
There are numerous reports about various types of tumors
found in patients with KTW syndrome, including malignant
peripheral nerve sheath tumor [6], angiosarcoma [3, 6], as-
trocytoma [2], hemangiopericytoma [4], and meningioma
[8]. The fact that heterogeneous tumor types and localiza-
tions are still emerging reinforces the fact that this syndrome
has a highly variable clinical expression.
In this patient, after a multidisciplinary work-up, the tumor
was resected radically and a histopathological diagnosis of
hemangioma was confirmed. Hemangiomas are benign tu-
mors and often grow slowly, although as demonstrated by this
case, a rapid-growing lesion can also occur and is not neces-
sarily associated with malignancy. Malignant transformation
of benign vascular tumors is uncommon and described only in
a single case report [7].
Radiological diagnosis in our case included metastasis
from an unknown primary tumor. Skull metastases are seen
in 15–25 % of all cancer patients and can originate from
breast, lung, prostate, thyroid, and renal cell cancer, as well
as from hematologic malignancies such as lymphoma, leuke-
mia, and multiple myeloma [5]. It is not uncommon for ma-
lignancies to present with solitary skull metastases [5]. The
occurrence of two similar tumors very close to each other, as
well as rapid growth, supported the differential diagnosis of
metastasis, but in the end, radiological analysis did not con-
tribute to the definitive diagnosis of hemangioma.
This case report adds to the literature of highly variable
tumor occurrence in KTW syndrome. A hemangioma in the
skull has never been described in this syndrome, emphasizing
that not only the type of tumor but also the location can be
highly variable.
CT, computed tomography; KTW, Klippel–Trénaunay–
Weber; MRI, magnetic resonance imaging.
Fig. 3 a The tumor was fixated to the skull, but not to the skin and
subcutaneous tissue, which could easily be separated from the tumor
surface. b No dural defects were detected after removal of the bone flap
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Fig. 4 aMacroscopic image of
both tumors fixated in the bone. b
Evident infiltration of the tabula
interna by the larger tumor. c, d
Hematoxylin and eosin (H & E)
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